Marinus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MRNS for the last quarter is 8.06 M USD, and it's 4.91% higher compared to the previous quarter. The net income of Q2 24 is -35.83 M USD.